Onderzoeker

Oliver Bechter

Disciplines:Laboratoriumgeneeskunde, Palliatieve zorg en zorg rond het levenseinde, Regeneratieve geneeskunde, Andere basiswetenschappen, Andere gezondheidswetenschappen, Verpleegkunde, Andere paramedische wetenschappen, Andere translationele wetenschappen, Andere medische en gezondheidswetenschappen

Publicaties

1 - 10 of 58 results

Is cancer biology different in older patients?(2021)
Auteurs: Yannick Van Herck, Annelies Feyaerts, Shabbir Alibhai, Demetris Papamichael, Lore Decoster, Yentl Lambrechts, Michael Pinchuk, Oliver Bechter, Jaime Herrera-Caceres, Frédéric Bibeau, et al.
Pagina's: E663 - E677
Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick Melanomas(2021)
Auteurs: Canan Guvenc, Asier Antoranz, Anna Szumera-Cieckiewicz, Pawel P Teterycz, Piotr R Rutkowski, Robert Rawson, Richard A Scolyer, John F Thompson, Julia Newton-Bishop, Marguerite Stas, et al.
Aantal pagina's: 10
Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma(2021)
Auteurs: Roberto Vendramin, Vasiliki Katopodi, Sonia Cinque, Angelina Konnova, Zorica Knezevic, Sara Adnane, Yvessa Verheyden, Panagiotis Karras, Ewout Demesmaeker, Francesca Maria Bosisio, et al.
Aantal pagina's: 27
Multitumor Case Series of Germline BRCA1, BRCA2 and CHEK2-Mutated Patients Responding Favorably on Immune Checkpoint Inhibitors.(2021)
Auteurs: Lisa Kinget, Oliver Bechter, Kevin Punie, Pascal Debruyne, Hilde Brems, Paul Clement, Eduard Roussel, Yannick Van Herck, Maarten Albersen, Marcella Baldewijns, et al.
Pagina's: 3227 - 3239
Evolutionary predictability of genetic versus nongenetic resistance to anticancer drugs in melanoma(2021)
Auteurs: Oskar Marin-Bejar, Aljosja Rogiers, Michael Dewaele, Julia Femel, Panagiotis Karras, Joanna Poźniak, Greet Bervoets, Nina Van Raemdonck, Dennis Pedri, Toon Swings, et al.
Pagina's: 1135 - +
Aantal pagina's: 23
Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East(2021)
Auteurs: Paolo Antonio Ascierto, Kristina Orlova, Giovanni Grignani, Monika Dudzisz-Sledz, Eyal Fenig, Vanna Chiarion Sileni, Nicola Fazio, Mahtab Samimi, Laurent Mortier, Christoffer Gebhardt, et al.
Pagina's: 1926 - 1934
Aantal pagina's: 9
Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy(2021)
Auteurs: Isaure Vanmeerbeek, Daniel Borras Morales, Jenny Sprooten, Oliver Bechter, Sabine Tejpar, Abhishek Garg
Pagina's: 108 - 119
Aantal pagina's: 12
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study(2021)
Auteurs: Alexander J Stratigos, Aleksandar Sekulic, Ketty Peris, Oliver Bechter, Sorilla Prey, Martin Kaatz, Karl D Lewis, Nicole Basset-Seguin, Anne Lynn S Chang, Stephane Dalle, et al.
Pagina's: 848 - 857
Aantal pagina's: 10
Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis(2021)
Auteurs: Youn H Kim, H Miles Prince, Sean Whittaker, Steven M Horwitz, Madeleine Duvic, Oliver Bechter, Jose A Sanches, Rudolf Stadler, Julia Scarisbrick, Pietro Quaglino, et al.
Pagina's: 411 - 421
Aantal pagina's: 11
Multiplexed Immunohistochemistry and Digital Pathology as the Foundation for Next-Generation Pathology in Melanoma: Methodological Comparison and Future Clinical Applications(2021)
Auteurs: Yannick Van Herck, Asier Antoranz, Madhavi Dipak Andhari, Giorgia Milli, Oliver Bechter, Frederik De Smet, Francesca Maria Bosisio
Aantal pagina's: 16

Onderzoeker

Oliver Bechter

Affiliaties

Projecten

Publicaties